menu
    • menu

    Company profile for BIOVICA INTERNATIONAL AB

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Biovica, a Swedish biotech company founded in 2009, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome. Our initial focus is breast cancer, where approximately 1600 new cases are diagnosed every day in the EU and US alone. By collaborating with world-leading cancer institutes as well as pharmaceutical companies launching next-genera...
    Biovica, a Swedish biotech company founded in 2009, develops and commercializes blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome. Our initial focus is breast cancer, where approximately 1600 new cases are diagnosed every day in the EU and US alone. By collaborating with world-leading cancer institutes as well as pharmaceutical companies launching next-generation therapies, we actively promote the growing drive towards personalized medicine. Improved patient survival plus lower healthcare costs are two anticipated and welcome outcomes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BIOVICA INTERNATIONAL ABSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Dag Hammarskjölds väg 54B Uppsala Science Park 752 37 Uppsala
    Telephone
    Telephone
    +46 (0) 18 44 44 830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biovica.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/biovica-international-ab
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/hashtag/biovica

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biovica Appoints Theis Kipling as New CEO
    Biovica Appoints Theis Kipling as New CEO

    07 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-07/theis-kipling-new-ceo-for-biovica

    PHARMIWEB
    07 Apr 2026
    Share Share
    AACR Data Support TKa Use And CDK Dose Optimization
    AACR Data Support TKa Use And CDK Dose Optimization

    18 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/new-aacr-data-expand-evidence-for-tka-in-immunotherapy-treated-patients-and-cdk-inhib-1148804

    ACCESSWIRE
    18 Mar 2026
    Share Share
    Biovica International AB: Q3 Interim Report, Nov 2025–Jan 2026
    Biovica International AB: Q3 Interim Report, Nov 2025–Jan 2026

    18 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/biovica-international-ab-q3-interim-report-nov-2025-jan2026-1148803

    ACCESSWIRE
    18 Mar 2026
    Share Share
    Biovica International AB Nominates Committee For AGM 2026
    Biovica International AB Nominates Committee For AGM 2026

    09 Mar 2026

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/nomination-committee-for-biovica-international-ab-for-the-2026-annual-general-meeting-1145322

    ACCESSWIRE
    09 Mar 2026
    Share Share
    Biovica Plans CEO Succession; Rylander To Step Down In 2026
    Biovica Plans CEO Succession; Rylander To Step Down In 2026

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/biovica-announces-planned-ceo-succession-anders-rylander-to-step-down-during-2026

    PHARMIWEB
    05 Mar 2026
    Share Share
    Biovica International AB - Q2 Interim report Aug - Oct 2025
    Biovica International AB - Q2 Interim report Aug - Oct 2025

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/biovica-international-ab-q2-interim-report-aug-oct-2025

    PHARMIWEB
    18 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search